Publications by authors named "Stenehjem E"

Understanding the impact of different Candida species on patient outcomes is crucial for effective management and treatment strategies. This study aims to comprehensively analyze the association between Candida species and mortality in documented candidemia. We queried TriNetX, a global research network database, to identify patients diagnosed with candidemia through polymerase chain reaction from 2020 to 2023.

View Article and Find Full Text PDF

Sepsis care delivery-including the initiation of prompt, appropriate antimicrobials-remains suboptimal. This study was conducted to determine direct and off-target effects of emergency department (ED) sepsis care reorganization. This pragmatic pilot trial enrolled adult patients who presented from November 2019 to February 2021 to an ED in Utah before and after implementation of a multimodal, team-based "Code Sepsis" protocol.

View Article and Find Full Text PDF

We examined the antibiotic prescribing rate for respiratory diagnoses (AXR) before and after onset of the COVID-19 pandemic in urgent care clinics. At the onset, AXR declined substantially due to changes in case mix. Using AXR as a stewardship metric requires monitoring of changes in case mix.

View Article and Find Full Text PDF

Background: Although psychiatric disorders have been associated with reduced immune responses to other vaccines, it remains unknown whether they influence COVID-19 vaccine effectiveness (VE). This study evaluated risk of COVID-19 hospitalization and estimated mRNA VE stratified by psychiatric disorder status.

Methods: In a retrospective cohort analysis of the VISION Network in four US states, the rate of laboratory-confirmed COVID-19-associated hospitalization between December 2021 and August 2022 was compared across psychiatric diagnoses and by monovalent mRNA COVID-19 vaccination status using Cox proportional hazards regression.

View Article and Find Full Text PDF

Background: Community-acquired pneumonia is a well-studied condition; yet, in the urgent care setting, patient characteristics and adherence to guideline-recommended care are poorly described. Within Intermountain Health, a nonprofit integrated US health care system based in Utah, more patients present to urgent care clinics (UCCs) than emergency departments (EDs) for pneumonia care.

Methods: We performed a retrospective cohort study 1 January 2019 through 31 December 2020 in 28 UCCs within Utah.

View Article and Find Full Text PDF

We conducted a post hoc analysis of an antibiotic stewardship intervention implemented across our health system's urgent-care network to determine whether there was a differential impact among patient groups. Respiratory urgent-care antibiotic prescribing decreased for all racial, ethnic, and preferred language groups, but disparities in antibiotic prescribing persisted.

View Article and Find Full Text PDF
Article Synopsis
  • - A study analyzed COVID-19 vaccine effectiveness among 521,206 emergency department visits and 139,548 hospitalizations between June 2021 and September 2022, focusing on adults with disabilities.
  • - Of the encounters, only 2% had documented disabilities, but those individuals represent a significant portion of hospitalizations (12%).
  • - The results showed that COVID-19 vaccines worked similarly for both disabled and non-disabled adults, highlighting the need for disabled individuals to keep their vaccinations current to protect against severe disease.
View Article and Find Full Text PDF
Article Synopsis
  • The study evaluated how urgent care clinicians prescribe antibiotics for conditions like sinusitis, acute otitis media, and pharyngitis, focusing on the choice of first-line antibiotics and their recommended durations of therapy.
  • Conducted within the Intermountain Health network over one year, the research analyzed clinician practices and the factors influencing prescription patterns using descriptive statistics and modeling techniques.
  • Results showed that first-line antibiotic selection was 75%, with variability based on condition; AOM had the highest selection rate (83%), while sinusitis had the lowest (69%). The study suggests a need for continued efforts to optimize antibiotic prescribing.
View Article and Find Full Text PDF

The rapid growth of telehealth services has brought about direct-to-consumer telemedicine platforms, enabling patients to request antibiotics online without a virtual or face-to-face consultation. While telemedicine aims to enhance accessibility, this trend raises significant concerns regarding appropriate antimicrobial use and patient safety. In this viewpoint, we share our first-hand experience with 2 direct-to-consumer platforms, where we intentionally sought inappropriate antibiotic prescriptions for nonspecific symptoms strongly indicative of a viral upper respiratory infection.

View Article and Find Full Text PDF

Background: The epidemiology of coronavirus disease 2019 (COVID-19) continues to develop with emerging variants, expanding population-level immunity, and advances in clinical care. We describe changes in the clinical epidemiology of COVID-19 hospitalizations and risk factors for critical outcomes over time.

Methods: We included adults aged ≥18 years from 10 states hospitalized with COVID-19 June 2021-March 2023.

View Article and Find Full Text PDF
Article Synopsis
  • Immunocompromised (IC) individuals face a higher risk of severe COVID-19 and have reduced vaccine effectiveness compared to non-immunocompromised (non-IC) individuals.
  • A study analyzed emergency department visits and hospitalizations among IC and non-IC adults, finding that vaccine effectiveness was significantly lower in IC patients, particularly for those who received 3 doses of mRNA vaccines or 1-2 doses of viral-vector vaccines.
  • Despite some protection from vaccines, the results indicate a pressing need for additional safeguards for IC adults, especially transplant recipients who showed the lowest vaccine effectiveness.
View Article and Find Full Text PDF
Article Synopsis
  • The study aims to evaluate the effectiveness of COVID-19 booster doses in preventing hospitalizations and emergency department visits, providing insight for public health policies.
  • Data was collected from over 1.2 million adults at five health systems during the Omicron variant's rise, showing that approximately 37% received a booster dose.
  • The median number needed to vaccinate (NNV) to prevent one hospitalization was 205, with lower NNV for adults aged 65 and older and those with health conditions, indicating booster effectiveness varies by age and health status.
View Article and Find Full Text PDF

Importance: Urgent Care (UC) encounters result in more inappropriate antibiotic prescriptions than other outpatient setting. Few stewardship interventions have focused on UC.

Objective: To evaluate the effectiveness of an antibiotic stewardship initiative to reduce antibiotic prescribing for respiratory conditions in a UC network.

View Article and Find Full Text PDF

Antibiotic stewardship interventions are urgently needed to reduce antibiotic overuse in hospitalized COVID-19 patients, particularly in small community hospitals (SCHs), who often lack access to infectious diseases (ID) and stewardship resources. We implemented multidisciplinary tele-COVID rounds plus tele-antibiotic stewardship surveillance in 17 SCHs to standardize COVID management and evaluate concurrent antibiotics for discontinuation. Antibiotic use was compared in the 4 months preintervention versus 10 months postintervention.

View Article and Find Full Text PDF
Article Synopsis
  • A study evaluated the effectiveness of the BNT162b2 COVID-19 vaccine on children and adolescents during the Omicron BA.4/BA.5 period, focusing on its ability to protect against mild to moderate and severe cases of COVID-19.
  • The research compared data from nearly 10,000 emergency department cases and over 70,000 controls, finding that vaccine effectiveness decreased over time, especially during the Omicron variant's spread.
  • It concluded that while the vaccine offered significant protection initially, especially against hospitalizations, booster doses enhanced effectiveness, highlighting the importance of completing the vaccination schedule for children and adolescents.
View Article and Find Full Text PDF

Objective: To examine the perspectives of caregivers that are not part of the antibiotic stewardship program (ASP) leadership team (eg, physicians, nurses, and clinical pharmacists), but who interact with ASPs in their role as frontline healthcare workers.

Design: Qualitative semistructured interviews.

Setting: The study was conducted in 2 large national healthcare systems including 7 hospitals in the Veterans' Health Administration and 4 hospitals in Intermountain Healthcare.

View Article and Find Full Text PDF
Article Synopsis
  • - During mid-2022, the Omicron BA.5 variant was the dominant strain of SARS-CoV-2 in the U.S., and bivalent mRNA vaccines were introduced containing both the original virus strain and components targeting Omicron BA.4/BA.5.
  • - A single bivalent booster was recommended for adults who had completed their primary vaccination and had not received a dose in the past two months, with effectiveness being evaluated from September to November 2022.
  • - Results showed that the bivalent booster significantly reduced the risk of COVID-19-related emergency visits (56% effectiveness) and hospitalizations (59% effectiveness) compared to those unvaccinated or with only monovalent vaccines, highlighting the importance
View Article and Find Full Text PDF
Article Synopsis
  • The Omicron sublineages BA.4 and BA.5 show increased immune evasion, reducing the effectiveness of COVID-19 mRNA vaccines in preventing illness among immunocompetent adults.
  • A study across 10 states focused on vaccinated adults, assessing the effectiveness of 2 to 4 vaccine doses during periods of BA.4 and BA.5 circulation, and examining the severity of COVID-19 in hospitalized patients across different Omicron sublineages.
  • Results indicated that in a large sample of emergency department and hospitalized patients, a significant portion tested positive for SARS-CoV-2, highlighting ongoing challenges in vaccine effectiveness and patient outcomes during these variant periods.
View Article and Find Full Text PDF
Article Synopsis
  • A study was conducted in the U.S. to evaluate the effectiveness of COVID-19 mRNA vaccines and previous SARS-CoV-2 infections during Delta and Omicron variant periods.
  • The research found that both 2- or 3-dose vaccinated individuals and those with a prior infection had high protection against hospitalizations and emergency care during the Delta period (91%-97%), but this protection decreased during the Omicron period (77%-90%).
  • The results highlight that staying up-to-date with COVID-19 vaccinations continues to offer significant protection against severe illness, regardless of prior exposure to the virus.
View Article and Find Full Text PDF

Background: Guidelines emphasize rapid antibiotic treatment for sepsis, but infection presence is often uncertain at initial presentation. We investigated the incidence and drivers of false-positive presumptive infection diagnosis among emergency department (ED) patients meeting Sepsis-3 criteria.

Methods: For a retrospective cohort of patients hospitalized after meeting Sepsis-3 criteria (acute organ failure and suspected infection including blood cultures drawn and intravenous antimicrobials administered) in 1 of 4 EDs from 2013 to 2017, trained reviewers first identified the ED-diagnosed source of infection and adjudicated the presence and source of infection on final assessment.

View Article and Find Full Text PDF

We validated  different coronavirus disease 2019 (COVID-19) (ICD-10) encounter definitions across 2 urgent care clinics. Sensitivity of definitions varied throughout the pandemic. Inclusion of COVID-19 and COVID-19-like illness (CLI) ICD-10s rendered highest sensitivity but lowest specificity.

View Article and Find Full Text PDF
Article Synopsis
  • The 2021-2022 influenza season in the U.S. experienced a resurgence following very low activity the previous year, primarily due to the A(H3N2) virus strain.
  • A study analyzed vaccine effectiveness (VE) among adults over 18 through hospital and urgent care visits, revealing that vaccination reduced the odds of influenza by 25% for both ED/UC encounters and hospitalizations.
  • The vaccine was notably less effective for older adults (≥65 years) and those with weakened immune systems, indicating a need for better vaccine formulations against A(H3N2) strains.
View Article and Find Full Text PDF

Background: Coronavirus disease 2019 (COVID-19) vaccination coverage remains lower in communities with higher social vulnerability. Factors such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exposure risk and access to healthcare are often correlated with social vulnerability and may therefore contribute to a relationship between vulnerability and observed vaccine effectiveness (VE). Understanding whether these factors impact VE could contribute to our understanding of real-world VE.

View Article and Find Full Text PDF